Hangzhou Biotest Biotech Co.,Ltd. (688767.SS)
CNY 38.92
(-0.97%)
CNY 38.92
(-0.97%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -1.9 Billion CNY | 1.45% |
| 2022 | -1.93 Billion CNY | -42.58% |
| 2021 | -1.35 Billion CNY | -441.93% |
| 2020 | -250.08 Million CNY | -1465.01% |
| 2019 | 18.32 Million CNY | 387.61% |
| 2018 | 3.75 Million CNY | -66.54% |
| 2017 | 11.22 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -1.6 Billion CNY | -2.9% |
| 2024 Q1 | -1.76 Billion CNY | 7.38% |
| 2024 Q2 | -1.56 Billion CNY | 11.33% |
| 2023 Q4 | -1.9 Billion CNY | -2.25% |
| 2023 FY | -1.9 Billion CNY | 1.45% |
| 2023 Q3 | -1.86 Billion CNY | -3.04% |
| 2023 Q2 | -1.8 Billion CNY | 4.27% |
| 2023 Q1 | -1.88 Billion CNY | 2.28% |
| 2022 Q3 | -1.77 Billion CNY | -3.99% |
| 2022 Q2 | -1.71 Billion CNY | 14.94% |
| 2022 Q1 | -2.01 Billion CNY | -48.41% |
| 2022 FY | -1.93 Billion CNY | -42.58% |
| 2022 Q4 | -1.93 Billion CNY | -8.63% |
| 2021 Q3 | -1.63 Billion CNY | -82.41% |
| 2021 FY | -1.35 Billion CNY | -441.93% |
| 2021 Q4 | -1.35 Billion CNY | 17.21% |
| 2021 Q1 | 261.17 Million CNY | 204.43% |
| 2021 Q2 | -897.4 Million CNY | -443.61% |
| 2020 Q4 | -250.08 Million CNY | 0.0% |
| 2020 Q2 | -240.65 Million CNY | 0.0% |
| 2020 FY | -250.08 Million CNY | -1465.01% |
| 2020 Q1 | -240.65 Million CNY | 0.0% |
| 2019 FY | 18.32 Million CNY | 387.61% |
| 2018 FY | 3.75 Million CNY | -66.54% |
| 2017 FY | 11.22 Million CNY | 0.0% |